Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Laurus Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:540222NSE Symbol: LAURUSLABSP/E(TTM):131.22
ISIN Demat:INE947Q01028Div & Yield %:0.15EPS(TTM):6.3
Book Value(Rs):84.5862053Market Cap ( Cr.):44606.21Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 5216.984812.395773.454707.044768.722797.34
Excise Duty0.000.000.000.000.000.00
Net Sales5216.984812.395773.454707.044768.722797.34
Other Income 100.4747.4215.9521.5527.325.81
Stock Adjustments 13.55102.48-40.82218.62296.45218.09
Total Income5331.004962.295748.584947.215092.493021.24
EXPENDITURE :      
Raw Materials 2476.742507.872671.652427.182471.581620.64
Power & Fuel Cost289.49309.67301.10188.52149.69132.62
Employee Cost 570.78531.93477.88417.57364.83299.90
Other Manufacturing Expenses 482.35491.94431.99326.34298.12191.38
Selling and Administration Expenses 393.12293.96323.95265.52260.60190.04
Miscellaneous Expenses 73.7229.6244.3015.3310.4810.62
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure4286.204164.994250.873640.463555.302445.20
Operating Profit1044.80797.301497.711306.751537.19576.04
Interest 182.20150.82145.7095.8665.9287.71
Gross Profit862.60646.481352.011210.891471.27488.33
Depreciation358.79345.01300.58235.48196.64183.85
Profit Before Tax503.81301.471051.43975.411274.63304.48
Tax153.8487.94270.78231.42334.9853.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-30.42-10.1720.27-6.10-16.46-15.57
Reported Net Profit380.39223.70760.38750.09956.11267.05
Extraordinary Items 40.37-0.57-0.14-0.85-0.63-0.67
Adjusted Net Profit340.02224.27760.52750.94956.74267.72
Adjst. below Net Profit 0.000.000.000.000.00-3.50
P & L Balance brought forward3367.613230.092577.181912.951031.88803.63
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 43.1386.18107.4785.8675.0435.30
P & L Balance carried down3704.873367.613230.092577.181912.951031.88
Dividend43.1386.18107.4785.8675.0416.04
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %60.0040.00100.00100.00100.0025.00
Earnings Per Share-Unit Curr7.054.1514.1213.9617.8224.98
Earnings Per Share(Adj)-Unit Curr7.054.1514.1213.9617.825.00
Book Value-Unit Curr84.6478.0675.3163.0550.54169.84